Dissociation of E-cadherin/β-catenin complex by MG132 and bortezomib enhances CDDP induced cell death in oral cancer SCC-25 cells
- 1 December 2015
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 29 (8) , 1965-1976
Abstract
No abstract availableKeywords
Funding Information
- National Nature Science Foundation of China (81072223, 81272949, 81000562)
This publication has 39 references indexed in Scilit:
- β-Catenin in oral cancer: An update on current knowledgeOral Oncology, 2014
- Nanotechnology-based drug delivery systems for treatment of oral cancer: a reviewInternational Journal of Nanomedicine, 2014
- Suppression of E-cadherin Mediates Gallotannin Induced Apoptosis in Hep G2 Hepatocelluar Carcinoma CellsInternational Journal of Biological Sciences, 2014
- Ubiquitin-proteasome system, a new anti-tumor targetActa Pharmacologica Sinica, 2013
- MG132, a proteasome inhibitor, induces apoptosis in tumor cellsAsia-Pacific Journal of Clinical Oncology, 2012
- Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal CarcinomaThe American Journal of Pathology, 2011
- Ubiquitin: Same Molecule, Different Degradation PathwaysCell, 2010
- Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of NoxaJournal of Biological Chemistry, 2006
- Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma CellsMolecular and Cellular Biology, 2004
- β‐catenin is a target for the ubiquitin–proteasome pathwayThe EMBO Journal, 1997